History | Home care: delivering personal care and practical support to older people living in their own homes | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Surveillance consultation

Surveillance consultation
Surveillance review proposal (PDF 360 KB)

Published:

06 November 2017
Comments form (MSWord 27 KB)

Published:

06 November 2017

Stakeholder list updated

Stakeholder list (PDF 49 KB)

Published:

01 November 2017

Guideline consultation

Guideline consultation information
Draft full guideline (PDF 1.58 MB)

Published:

05 March 2015
Draft short guideline (PDF 347 KB)

Published:

05 March 2015
Equality impact assessment (PDF 250 KB)

Published:

05 March 2015
Economic plan (PDF 18 KB)

Published:

05 March 2015
Draft guideline appendices information
Appendix A (PDF 1.04 MB)

Published:

05 March 2015
Appendix B (PDF 3.05 MB)

Published:

05 March 2015
Appendix C1 (PDF 509 KB)

Published:

05 March 2015
Appendix C2 (PDF 18 KB)

Published:

05 March 2015
Appendix C3 (PDF 368 KB)

Published:

05 March 2015
Appendix D (PDF 306 KB)

Published:

05 March 2015

Consultation comments table

Consultation comments table (PDF 869 KB)

Published:

21 September 2015

Equality impact assessment

Equality impact assessment (PDF 108 KB)

Published:

21 September 2015

Health economic plan

Health economic plan
Economic plan (PDF 18 KB)

Published:

19 January 2015
Search strategies (PDF 545 KB)

Published:

19 January 2015
Review questions (PDF 714 KB)

Published:

19 January 2015

Final scope

Final scope
Scope consultation comments table (PDF 360 KB)

Published:

14 August 2014
Final scope (PDF 162 KB)

Published:

14 August 2014
Equality impact assessment (PDF 239 KB)

Published:

14 August 2014

GDG membership list

GDG membership list (PDF 100 KB)

Published:

05 March 2015

GDG minutes

GDG minutes
GDG 10 (PDF 375 KB)

Published:

16 March 2015
GDG 9 (PDF 374 KB)

Published:

16 March 2015
GDG 8 (PDF 390 KB)

Published:

16 March 2015
GDG 7 (PDF 318 KB)

Published:

03 November 2014
GDG 6 (PDF 431 KB)

Published:

03 November 2014
GDG 5 (PDF 573 KB)

Published:

01 October 2014
GDG 4 (PDF 602 KB)

Published:

01 October 2014
GDG 3 (PDF 407 KB)

Published:

14 August 2014
GDG 2 (PDF 403 KB)

Published:

14 August 2014
GDG 1 (PDF 407 KB)

Published:

14 August 2014

Scope consultation

Scope consultation information
Draft scope (PDF 193 KB)

Published:

14 August 2014
Scoping workshop notes (PDF 217 KB)

Published:

14 August 2014